GeminIQ Website Logo

Viewing JUNS free

Subscribe for full history, 90+ metrics, screener, watchlist...

JUPITER NEUROSCIENCES, INC.

JUNS

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash
22412340
Prepaid Expense And Other Assets Current
------0-
Accounts Receivable Net Current
0-0-----
Prepaid Expense Current
1111111-
Inventory Net
000-----
Other Assets Current
00000000
Assets Current
33523450
Operating Lease Right Of Use Asset
00000000
Prepaid Expense Noncurrent
0111111-
Other Assets Noncurrent
10000000
Assets
44634560
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current
10101001
Deferred Compensation Liability Current
11122112
Interest Payable Current
--000000
Contract With Customer Liability Current
---0----
Deferred Revenue
--0-----
Operating Lease Liability Current
00000000
Convertible Notes Payable Current
255----1
Derivative Liabilities Current
-------1
Customer Refund Liability Current
00------
Liabilities Current
47733226
Convertible Long Term Notes Payable
-------0
Operating Lease Liability Noncurrent
-----000
Liabilities
47733226
Stockholders Equity
Common Stock Value
00000000
Additional Paid In Capital
3934333231313019
Retained Earnings Accumulated Deficit
-39-37-35-32-30-28-26-24
Debt Instrument Unamortized Discount Current
------00
Stockholders Equity
-0-3-20134-6
Liabilities And Stockholders Equity
44634560
Debt Instrument Unamortized Discount Noncurrent
------00
Preferred Stock Par Or Stated Value Per Share
00000000
Preferred Stock Shares Authorized
55555555
Common Stock Par Or Stated Value Per Share
00000-00
Common Stock Shares Authorized
500500500125125125125125
Common Stock Shares Issued
10000000
Shares Outstanding
10000000

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-30.86%-36.29%-74.29%---------
202529.35%173.63%125.54%17.83%18.60%3.10%-14.93%-24.63%-60.60%2.63%-37.37%-37.37%
2024-------59.82%-92.41%-94.41%-11.43%-16.43%61.43%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.66
0.51
0.65
0.65
1.07
1.91
2.31
0.00
Quick Ratio
0.42
0.37
0.53
0.34
0.78
1.51
1.93
0.00
Working Capital
-1.33M
-3.32M
-2.57M
-886.48K
191.15K
1.72M
2.64M
-5.68M
Leverage & Debt
Debt to Equity
-11.16
-2.42
-4.04
43.87
1.96
0.62
0.49
-1.01
Interest Coverage TTM
-35.95
-50.88
-134.94
-60.17
-27.50
-
-
-
Debt Ratio
1.10
1.70
1.33
0.98
0.66
0.38
0.33
68.23
Efficiency & Turnover
Asset Turnover TTM
0.01
0.00
0.00
0.00
0.00
-
-
-
Days Sales Outstanding TTM
87.14
-
-
-
-
-
-
-
Receivables Turnover TTM
4.19
-
0.00
-
-
-
-
-
Per Share Metrics
Diluted EPS TTM
-16.50
-19.57
-18.77
-17.49
-14.06
-
-
-
Free Cash Flow Per Share TTM
-12.34
-12.33
-11.75
-12.54
-10.71
-
-
-
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
-
-
-
Margin Metrics
Operating Profit Margin TTM
-22,872.89%
-50,041.38%
-
-
-
-
-
-
Net Profit Margin TTM
-21,445.37%
-49,206.46%
-
-
-
-
-
-
Growth Metrics
Net Income Growth (1Y)
47.87%
-
-
-
-
-
-
-
EPS Growth (1Y)
17.33%
-
-
-
-
-
-
-
Valuation Metrics
P/E TTM
-0.01
-0.02
-0.05
-0.10
-0.07
-
-
-
P/B TTM
-0.33
-0.06
-0.26
13.88
0.34
0.09
0.98
-
P/S TTM
2.78
9.45
-
-
-
-
-
-
Market Cap
119.32K
176.31K
469.77K
796.81K
451.26K
268.57K
4.10M
-
Enterprise Value
125.91K
2.64M
1.98M
73.01K
-1.43M
-2.44M
326.61K
-
Calculated Values
Free Cash Flow TTM
-6.88M
-5.78M
-5.41M
-5.68M
-4.74M
-
-
-
Net Debt
6.60K
2.46M
1.51M
-723.80K
-1.88M
-2.71M
-3.77M
649.12K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-07-01Purchase
Owner: Silva, Alison D.
Title: Pres + Chief Business Officer
Shares: 750
Price/Share: $1.03
Value: $772.50
Shares Owned: 112,777
Relationship: Director,Officer
Ownership: Direct
2025-07-01Purchase
Owner: Rosen, Christer
Title: CEO and Chairman
Shares: 3,600
Price/Share: $1.02
Value: $3,672.00
Shares Owned: 11,078,892
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2025-06-30Purchase
Owner: Silva, Alison D.
Title: Pres + Chief Business Officer
Shares: 950
Price/Share: $1.03
Value: $978.50
Shares Owned: 112,027
Relationship: Director,Officer
Ownership: Direct
2025-06-30Purchase
Owner: Rosen, Christer
Title: CEO and Chairman
Shares: 7,650
Price/Share: $1.02
Value: $7,803.00
Shares Owned: 11,075,292
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
2.61%
Inst. Shares: 921,314
Shares Outstanding: 35,255,588
2025-12-31
1.84%
Inst. Shares: 638,871
Shares Outstanding: 34,628,588
2025-09-30
1.14%
Inst. Shares: 389,551
Shares Outstanding: 34,039,906
2025-06-30
0.20%
Inst. Shares: 65,022
Shares Outstanding: 33,180,966
2025-03-31
1.10%
Inst. Shares: 363,142
Shares Outstanding: 33,103,860

JUPITER NEUROSCIENCES, INC. (JUNS) — SEC Financial Statements & Analysis

JUPITER NEUROSCIENCES, INC. (JUNS) is a pharmaceutical preparations company, incorporated in DE. JUPITER NEUROSCIENCES, INC. trades on Nasdaq as: JUNS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), JUPITER NEUROSCIENCES, INC. reported a Debt-to-Equity ratio of -11.16x, a Price-to-Sales (P/S) ratio of 2.78x (TTM), a Price-to-Book (P/B) ratio of -0.33x (TTM), at a market cap of $119.32K. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
-11.16x
P/S TTM
2.78x
P/B TTM
-0.33x
Market Cap
$119.32K

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is JUPITER NEUROSCIENCES, INC. in?

JUPITER NEUROSCIENCES, INC. (JUNS) operates in the Pharmaceutical Preparations industry.

What is JUNS's market cap?

JUPITER NEUROSCIENCES, INC. (JUNS) has a market capitalization of $119.32K as of 2026-06-30.

What exchange does JUNS trade on?

JUPITER NEUROSCIENCES, INC. (JUNS) trades on the Nasdaq.

Where is JUPITER NEUROSCIENCES, INC. incorporated?

JUPITER NEUROSCIENCES, INC. is incorporated in DE.

Wall Street's data.
Main Street's price.